Food/Recall·FDA Recalls

Ghirardelli Chocolate Company Recalls Powdered Beverage Mixes Because of Possible Health Risk

HighPublished Apr 27, 2026· AI-analyzed May 4, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Ghirardelli Chocolate Company is voluntarily recalling specific powdered beverage mixes due to potential Salmonella contamination. This action was prompted by a underlying recall of milk powder from California Dairies, Inc. used in the products.

Who it affects

Ghirardelli Chocolate Company, milk powder suppliers, food safety professionals, and distributors or retailers handling these specific powdered beverage mixes.

Why it matters

This situation highlights the significant regulatory and safety risks associated with ingredient-level contamination in the supply chain. A recall of a bulk ingredient like milk powder necessitates an immediate trace-back and trace-forward analysis by food manufacturers to prevent widespread distribution of contaminated finished goods. Regulatory teams must monitor cross-contamination risks and ensure that supplier qualification programs account for such microbiological hazards.

Practical takeaway

Quality teams should immediately verify if their inventory includes the affected powdered beverage mixes or milk powders sourced from California Dairies, Inc. and initiate standard recall procedures and quarantine protocols if a match is found. Supply chain personnel should assess the impact on downstream finished goods and prepare to communicate risk to distribution partners.

FDA source material

Ghirardelli Chocolate Company of San Leandro, California is voluntarily recalling certain powdered beverage mixes because they have the potential to be contaminated with Salmonella. This action follows a California Dairies, Inc. milk powder recall due to a concern of potential Salmonella contaminati

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.